EvoEndo develops systems that enable unsedated endoscopic procedures through a combination of sterile single-use.
EvoEndo's investors include TLP Investment Partners, MedTech Innovator, Sunshine Foundation, GI Opportunity Fund 1, Paul Meister.
EvoEndo is headquartered in Englewood, United States.
EvoEndo develops systems that enable unsedated endoscopic procedures through a combination of sterile single-use.
EvoEndo is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"EvoEndo — Funding & Investors." VCBacked, April 13, 2023, https://www.vcbacked.co/company/evoendo. Accessed October 21, 2026.
VCBacked. (2023). EvoEndo — Funding & Investors. Retrieved October 21, 2026, from https://www.vcbacked.co/company/evoendo
{{cite web |title=EvoEndo — Funding & Investors |url=https://www.vcbacked.co/company/evoendo |website=VCBacked |access-date=October 21, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated